Ingr Cancer Research Results
Ingr, Components/Ingredients: Click to Expand ⟱
| Source: |
| Type: |
| Main Active Components
|
Scientific Papers found: Click to Expand⟱
| - |
Case Report, |
Melanoma, |
NA |
|
|
|
GutMicro↑, Ingr?, CD8+↑, CR↑, CR↑, Synergy↑,
Risk↓, Ingr?, *antiOx?, *Inflam↓, *Estro↓, *Ingr↑, *neuroP↑, *Obesity↓, TumMeta↓, TumCP↓, *AntiAg↑, *AntiDiabetic↑, *ROS↓, *GutMicro↑, FOXM1↓, PCNA↓, Ki-67↓, CDK2↓, Akt↓, PDGF↓, ERK↓, p‑GSK‐3β↓, IGFR↓, p‑MDM2↓, EGFR↓, FASN↓, CYP3A4↓, COX2/PTGS2↓, Cyt‑c↑, cl‑PARP↑, Casp3↑, p‑P53↑, Bcl-2↓, VEGF↓, VEGFR2/KDR/Flk1↓, BRCA1↓, BRCA2↓, survivin↓, GADD45A↓, FAK↓, pax↓, Rho↓, Rac1↓, Cdc42↓, MMP2↓, TIMP1↑, TIMP2↑, angioG↓, MMP↓, ChemoSen↑,
Risk↓, TumCG↓, ROS↑, TumCCA↑, Apoptosis↑, Ingr?, chemoPv↑, P450↓, SXR↓, CYP3A4↓, NRF2↑, ARE↑, HO-1↑, p38↓, TrxR↑, Trx↑, NF-kB↓, AP-1↓, BioAv↑, Akt↓, STAT3↓, HDAC↓, VEGF↓, MMP2↓, Hif1a↓, CD31/PECAM-1↓, PI3K↓, PDK1 / PDPK1↓, mTOR↓, FOXO1↓, FOXO3↓, BIM↑, p27/CDKN1B↑, P21↑, HER2/EBBR2↓, EGFR↓, Bcl-xL↓, XIAP↓, ROS↓, Zeb1↓, Snail↓, E-cadherin↑, MMP2↓, MMP9↓, ROS↑, MMP↓, Casp↑, DNAdam↑, TumCCA↑, γH2AX↑, CSCs↓, OCT4↓, SOX2↓, Nanog↓, NOTCH2↑, selectivity↝, ETC↓, compI↓, compIII↓, OCR↓, Synergy↑, ChemoSen↑, RadioS↑, Synergy↑, Synergy↑, Synergy↑, Synergy↑, Synergy↑,
| - |
vitro+vivo, |
Oral, |
SCC4 |
|
|
|
- |
in-vitro, |
Tong, |
SCC9 |
|
|
|
- |
in-vitro, |
SCC, |
CAL27 |
|
|
|
TumCG↓, TumMeta↓, *toxicity↓, Ingr?, chemoPv↑, compI↓, mitResp↓, ETC↓, AMPK↑, STAT3↓, ox-PrxI↑, Dose↝, Ki-67↓, STAT3↓, P70S6K↓, HK2↓, survivin↓, BioAv↝, Half-Life↝, ROS↑,
| - |
in-vitro, |
Oral, |
CAL27 |
|
|
|
- |
in-vitro, |
Tong, |
SCC9 |
|
|
|
- |
in-vitro, |
SCC, |
SCC4 |
|
|
|
Ingr?, BioAv↓, other↝, BioAv↓, Half-Life↓,
| - |
in-vitro, |
BC, |
SkBr3 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF-10AT |
|
|
|
Ingr↝, tumCV↓, TumCCA↑, cycD1/CCND1↓, CDK4↓, cycE/CCNE↓, ChemoSen↑, Imm↑, Dose↝, Ingr?,
| - |
in-vitro, |
GC, |
AGS |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
CRC, |
HT-29 |
|
|
|
Ingr↝, Ingr?, eff↑, TumCP↓, Ingr↝,
| - |
in-vitro, |
lymphoma, |
U937 |
|
|
|
Ingr?, Apoptosis↑, TumCP↓, Casp3↑, Casp9↑, Bcl-2↓, Bcl-xL↓, XIAP↓, IAP1↓, Cyt‑c↑, MMP↓, cl‑PARP↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
DLD1 |
|
|
|
Ingr↝, BAX↑, Bcl-2↓, MMP↓, cl‑Casp9↑, cl‑Casp3↑, ROS↑, eff↓, Ingr?,
Ingr?, selectivity↑, Casp7↑, AIF↑, HO-1↑, ROS↑, P53↑, Bcl-2↓,
Ingr?, TumCP↓, Apoptosis↑, Dose↝,
Showing Research Papers: 1 to 11 of 11
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 11
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ARE↑, 1, HO-1↑, 2, NRF2↑, 1, ox-PrxI↑, 1, ROS↓, 1, ROS↑, 5, Trx↑, 1, TrxR↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
compI↓, 2, compIII↓, 1, ETC↓, 2, mitResp↓, 1, OCR↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, FASN↓, 1, p‑GSK‐3β↓, 1, HK2↓, 1, PDK1 / PDPK1↓, 1,
Cell Death(tgid=5) ⓘ
AIF↑, 1, Apoptosis↑, 3, BAX↑, 1, Bcl-2↓, 4, Bcl-xL↓, 2, BIM↑, 1, Casp↑, 1, Casp3↑, 2, cl‑Casp3↑, 1, Casp7↑, 1, Casp9↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 2, IAP1↓, 1, p‑MDM2↓, 1, p38↓, 1, survivin↓, 2, XIAP↓, 2,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt↓, 2, EGFR↓, 2, ERK↓, 1, HER2/EBBR2↓, 1, IGFR↓, 1, mTOR↓, 1, P70S6K↓, 1, PI3K↓, 1, STAT3↓, 3,
Transcription & Epigenetics(tgid=7) ⓘ
FOXM1↓, 1, FOXO1↓, 1, FOXO3↓, 1, HDAC↓, 1, OCT4↓, 1, other↝, 1, SOX2↓, 1, tumCV↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
BRCA1↓, 1, BRCA2↓, 1, DNAdam↑, 1, P53↑, 1, p‑P53↑, 1, cl‑PARP↑, 2, PCNA↓, 1, γH2AX↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 1, CDK4↓, 1, cycD1/CCND1↓, 1, cycE/CCNE↓, 1, GADD45A↓, 1, Ki-67↓, 2, P21↑, 1, p27/CDKN1B↑, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CSCs↓, 1, Ki-67↓, 2, Nanog↓, 1, NOTCH2↑, 1, TumCG↓, 2, TumCP↓, 4,
Migration(tgid=13) ⓘ
AP-1↓, 1, Cdc42↓, 1, E-cadherin↑, 1, FAK↓, 1, MMP2↓, 3, MMP9↓, 1, pax↓, 1, PDGF↓, 1, Rac1↓, 1, Rho↓, 1, Snail↓, 1, TIMP1↑, 1, TIMP2↑, 1, TumMeta↓, 2, Zeb1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, CD31/PECAM-1↓, 1, Hif1a↓, 1, VEGF↓, 2, VEGFR2/KDR/Flk1↓, 1,
Barriers & Transport(tgid=15) ⓘ
MMP↓, 4,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CD8+↑, 1, COX2/PTGS2↓, 1, Imm↑, 1, NF-kB↓, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
SXR↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 2, BioAv↑, 1, BioAv↝, 1, ChemoSen↑, 3, CYP3A4↓, 2, Dose↝, 3, eff↓, 1, eff↑, 1, Half-Life↓, 1, Half-Life↝, 1, P450↓, 1, RadioS↑, 1, selectivity↑, 1, selectivity↝, 1, Synergy↑, 7,
Clinical Biomarkers(tgid=22) ⓘ
BRCA1↓, 1, EGFR↓, 2, FOXM1↓, 1, HER2/EBBR2↓, 1,
Functional Outcomes(tgid=23) ⓘ
chemoPv↑, 2, CR↑, 2, Risk↓, 2,
Infection & Microbiome(tgid=24) ⓘ
GutMicro↑, 1,
Ingredients & Constituents(tgid=25) ⓘ
Ingr?, 11, Ingr↝, 4,
Total Targets: 127
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx?, 1, ROS↓, 1,
Migration(tgid=13) ⓘ
AntiAg↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
Estro↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiDiabetic↑, 1, neuroP↑, 1, Obesity↓, 1, toxicity↓, 1,
Infection & Microbiome(tgid=24) ⓘ
GutMicro↑, 1,
Ingredients & Constituents(tgid=25) ⓘ
Ingr↑, 1,
Total Targets: 11
Scientific Paper Hit Count for: Ingr, Components/Ingredients
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:1794 State#:% Dir#:0
wNotes=0 sortOrder:rid,rpid
Home Page